//
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)
Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction
Sodium-Glucose Co-Transporter 2 Inhibitors and Insights from Biomarker Measurement in Heart Failure Patients
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patients
The multiple causes and treatments of heart failure: focus on genetic and molecular mechanisms and non-pharmacological interventions
Diagnostic performance of congestion score index evaluated from chest radiography for acute heart failure in the emergency department: A retrospective analysis from the PARADISE cohort
SGLT2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction: A Meta-Analysis of the EMPEROR-Reduced and DAPA-HF Trials